Medicare Enrolled

Dr. Vitaly Borodin, M.D.

Cytopathology Physician · Tampa, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3301 BAYSHORE BLVD UNIT 1709, Tampa, FL 33629
4843507158
In practice since 2013 (12 years)
NPI: 1659702553 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Borodin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borodin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Borodin

Dr. Vitaly Borodin is a cytopathology physician in Tampa, FL, with 12 years in practice. Based on federal Medicare data, Dr. Borodin performed 1,327 Medicare services across 951 unique beneficiaries.

Between the years covered by Open Payments, Dr. Borodin received a total of $43 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Borodin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 42% volume in FL$ $43 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,327
Medicare services
Top 42% in FL for cytopathology physician
951
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~111 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tissue pathology examination, moderate complexity438$29$178
Tissue staining for diagnosis, additional188$22$234
Tissue staining for diagnosis, initial140$27$249
Cell examination of specimen, selective cellular enhancement technique97$22$152
Pathology examination of tissue using a microscope, moderately high complexity96$66$586
Preparation of tissue for examination by removing any calcium present96$10$56
Pathology examination of tissue using a microscope, moderately low complexity86$9$137
Evaluation of fine needle aspirate with interpretation and report35$53$207
Pathology examination of tissue using a microscope, limited examination32$4$67
Pathology examination of specimen during surgery, first tissue block31$49$244
Special stained specimen slides to examine tissue, each multiplex procedure27$30$372
Special stained specimen slides to identify organisms including interpretation and report19$21$181
Blood smear interpretation by physician with written report16$19$125
Pathology examination of tissue using a microscope13$5$73
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method13$141$848
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
1.0% medium
96.7% routine

Industry Payment Transparency

Open Payments through 2021 ↗
$43
Total received (2019-2021)
Avg $22/year across 2 years
Bottom 24% in FL for cytopathology physician
2
Companies
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$43 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$15
2019
$29

Payments by company (2021)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$29
Roche Diagnostics Corporation
$15
Top 3 companies account for 100.0% of total payments
Associated products mentioned in payments ›
CINtec PLUS Cytology
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for a cytopathology physician in Tampa?
Compare cytopathology physicians in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse cytopathology physicians nearby

Geographic Context

Cytopathology Physicians within 10 mi
16
Per 100K population
1.1
County median income
$75,011
Nearest hospital
HCA FLORIDA SOUTH TAMPA HOSPITAL
1.5 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2021
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Borodin is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Borodin experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Borodin performed 438 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Borodin receive payments from pharmaceutical companies?
Yes. Dr. Borodin received a total of $43 from 2 companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borodin's costs compare to other cytopathology physicians in Tampa?
Dr. Borodin's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borodin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →